| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.11 | 0.3 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |